BPH - Benign Prostatic Enlargement
Endoscopic Outlet Surgery versus Medical Therapy for Benign Prostatic Hyperplasia: Impact on Incident Mood Disorders.
- Details
To compare incidence of new-onset depression, anxiety, suicidal ideation, and bipolar disorder among men with BPH treated with endoscopic outlet surgery versus medical management.
Using the TriNetX Research Network, we conducted a retrospective cohort study with two parallel 1:1 propensity score-matched (PSM) analyses comparing endoscopic outlet surgery (TURP, GreenLight PVP, laser enucleation of the prostate, or Aquablation) to (1) third-generation alpha-blocker monotherapy and (2) combination alpha-blocker/5α-reductase inhibitor therapy.
Trends in rates and outcomes of benign prostatic hyperplasia surgeries: a retrospective cohort study using the ACS-NSQIP database (2008-2021).
- Details
Advancements in surgical techniques have led to a shift in the types of procedures performed for BPH. This study aims to analyze trends in rates and outcomes of surgical procedures for BPH between 2008 and 2021.
Tracking outcome changes in benign prostatic hyperplasia trials: a version history review of ClinicalTrials.gov records.
- Details
Benign prostatic hyperplasia (BPH) is a common condition with trials that frequently rely on subjective outcomes. While federal regulations require prospective outcome registration in ClinicalTrials.
Imaging of Complications after Prostate Interventions.
- Details
Prostate interventions are increasingly employed in management of benign prostatic hyperplasia (BPH) and prostate cancer. Routinely performed procedures include a widening array of surgical therapies for BPH, prostate needle biopsy, focal therapies, radical prostatectomy, and radiation therapy.
Knowledge, Attitude, and Practice Towards Benign Prostatic Hyperplasia Among Men Aged 50 and Above.
- Details
This study aimed to investigate the knowledge, attitude, and practice (KAP) regarding benign prostatic hyperplasia (BPH) among men aged 50 years and above.
A cross-sectional survey was conducted on men aged 50 years and above at four medical institutions in Beijing, China between July 1, 2023, and April 30, 2024.
Study of risk factors of early reintervention after prostate laser photovaporization using Greenlight 180 W-XPS.
- Details
Greenlight laser prostate photovaporization (PVP) is an alternative treatment for benign prostatic hyperplasia. However, compared to standard techniques such as transurethral resection of the prostate (TURP) and holmium laser prostate enucleation, it has certain limitations with respect to reintervention rates.
Clinical Outcomes of Benign Prostatic Hyperplasia Surgery in Men with Detrusor Underactivity Versus Normal Contractility: A Systematic Review and Meta-Analysis - Beyond the Abstract
- Details
Holmium Laser Enucleation of the Prostate After Prostatic Urethral Lift: The State of Bother - Beyond the Abstract
- Details
High-frequency irreversible electroporation versus transurethral resection of the prostate for benign prostatic hyperplasia (GIANT): a single-centre, randomised, double-blind, phase 3, non-inferiority trial.
- Details
Transurethral resection of the prostate (TURP) is the gold standard for treating benign prostatic hyperplasia (BPH) but frequently causes retrograde ejaculation and bleeding. High-frequency irreversible electroporation (H-FIRE) is a non-thermal ablation technique offering tissue selectivity.
Frailty burden and symptomatic BPH/LUTS in aging men: evidence from two nationally representative population-based studies.
- Details
The frailty index (FI) is a well-established marker of biological aging and a widely validated predictor of adverse health outcomes in older adults. However, its association with symptomatic benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS) has not been well defined in nationally representative populations.